# Egetis Therapeutics – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/egetis-therapeutics
Company JSON: https://spela.port0.org/company/egetis-therapeutics/company.json
Documents JSON: https://spela.port0.org/company/egetis-therapeutics/documents.json
Updated: 2026-08-06T01:47:10Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/egetis-therapeutics/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/egetis-therapeutics/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/egetis-therapeutics/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/egetis-therapeutics/market/instrument.json
- SEC sammanfattning JSON: https://spela.port0.org/company/egetis-therapeutics/market/sec-summary.json
- MFN manifest JSON: https://spela.port0.org/company/egetis-therapeutics/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/egetis-therapeutics/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/egetis-therapeutics/reports
- JSON: https://spela.port0.org/company/egetis-therapeutics/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b6eed573445c5007fad22497e9ea6e15a&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=bd422734e05445b3d94aa01527b8e5ec3&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b44b80c3eb35069e5d3ef27619cf43fbf&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b2bc7bcb707477cbbca001cd7f5bbfe7f&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=bdc02099a782352223cdc8a80791bb306&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b04407352577b944f1db775fbba6cc0a5&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b5e86dbf640e2107ef0195a10490f2570&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b54c8861ab69dd5eb6b82cb4c09c9ecfd&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b3079030691d8cfcfff1aa18663986305&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=bf3afba6a33edcdc6e6188bc8f6cfd633&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b5d81534397dc40acd5a145f1bab09c3c&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=bf825d303bbb3f339d86185713acda286&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=bda8425e5dd15751763854e309cc2a802&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b4b37225e0947f3a95bc7db73dc9508a9&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b29970ae3290eb0fee17334f1634fc4f4&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b8eda6e67ac908da1643016b7ac20eb8f&lang=sv&src=listed

## Morningstar Institutions
- Page: https://spela.port0.org/company/egetis-therapeutics/morningstar
- Summary: https://spela.port0.org/company/egetis-therapeutics/morningstar/summary.txt
- Screenshot: https://spela.port0.org/company/egetis-therapeutics/morningstar/screenshot.png

## Finansinspektionen
- Page: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen
- Summary: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/egetis-therapeutics/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-002.html
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/egetis-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/egetis-therapeutics/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt